These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31177990)

  • 1. An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).
    Tauziède-Espariat A; Debily MA; Castel D; Grill J; Puget S; Sabel M; Blomgren K; Gareton A; Dangouloff-Ros V; Lechapt E; Boddaert N; Varlet P
    Acta Neuropathol Commun; 2019 Jun; 7(1):87. PubMed ID: 31177990
    [No Abstract]   [Full Text] [Related]  

  • 2. The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts.
    Tauziède-Espariat A; Debily MA; Castel D; Grill J; Puget S; Roux A; Saffroy R; Pagès M; Gareton A; Chrétien F; Lechapt E; Dangouloff-Ros V; Boddaert N; Varlet P
    Acta Neuropathol Commun; 2020 Jul; 8(1):104. PubMed ID: 32646492
    [No Abstract]   [Full Text] [Related]  

  • 3. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
    Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
    Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
    Chan E; Bollen AW; Sirohi D; Van Ziffle J; Grenert JP; Kline CN; Tihan T; Perry A; Gupta N; Solomon DA
    Acta Neuropathol; 2017 Oct; 134(4):671-673. PubMed ID: 28776091
    [No Abstract]   [Full Text] [Related]  

  • 5. Brainstem angiocentric gliomas with MYB-QKI rearrangements.
    D'Aronco L; Rouleau C; Gayden T; Crevier L; Décarie JC; Perreault S; Jabado N; Bandopadhayay P; Ligon KL; Ellezam B
    Acta Neuropathol; 2017 Oct; 134(4):667-669. PubMed ID: 28803398
    [No Abstract]   [Full Text] [Related]  

  • 6. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    Dahl NA; Donson AM; Sanford B; Wang D; Walker FM; Gilani A; Foreman NK; Tinkle CL; Baker SJ; Hoffman LM; Venkataraman S; Vibhakar R
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):345-353. PubMed ID: 33749791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.
    Schoof M; Kordes U; Volk AE; Al-Kershi S; Kresbach C; Schüller U
    Acta Neuropathol; 2021 Sep; 142(3):591-593. PubMed ID: 34264394
    [No Abstract]   [Full Text] [Related]  

  • 8. An epigenetic therapy for diffuse intrinsic pontine gliomas.
    Ramaswamy V; Remke M; Taylor MD
    Nat Med; 2014 Dec; 20(12):1378-9. PubMed ID: 25473916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition.
    Taylor IC; Hütt-Cabezas M; Brandt WD; Kambhampati M; Nazarian J; Chang HT; Warren KE; Eberhart CG; Raabe EH
    J Neuropathol Exp Neurol; 2015 Aug; 74(8):778-90. PubMed ID: 26115193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.
    Mackay A; Burford A; Carvalho D; Izquierdo E; Fazal-Salom J; Taylor KR; Bjerke L; Clarke M; Vinci M; Nandhabalan M; Temelso S; Popov S; Molinari V; Raman P; Waanders AJ; Han HJ; Gupta S; Marshall L; Zacharoulis S; Vaidya S; Mandeville HC; Bridges LR; Martin AJ; Al-Sarraj S; Chandler C; Ng HK; Li X; Mu K; Trabelsi S; Brahim DH; Kisljakov AN; Konovalov DM; Moore AS; Carcaboso AM; Sunol M; de Torres C; Cruz O; Mora J; Shats LI; Stavale JN; Bidinotto LT; Reis RM; Entz-Werle N; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Monje M; Debily MA; Castel D; Grill J; Hawkins C; Nikbakht H; Jabado N; Baker SJ; Pfister SM; Jones DTW; Fouladi M; von Bueren AO; Baudis M; Resnick A; Jones C
    Cancer Cell; 2017 Oct; 32(4):520-537.e5. PubMed ID: 28966033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular landscape of pediatric diffuse intrinsic pontine gliomas: about 22 cases.
    El Ayoubi R; Boisselier B; Rousseau A
    J Neurooncol; 2017 Sep; 134(2):465-467. PubMed ID: 28589424
    [No Abstract]   [Full Text] [Related]  

  • 12. Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
    Schoof M; Godbole S; Albert TK; Dottermusch M; Walter C; Ballast A; Qin N; Olivera MB; Göbel C; Neyazi S; Holdhof D; Kresbach C; Peter LS; Epplen GD; Thaden V; Spohn M; Blattner-Johnson M; Modemann F; Mynarek M; Rutkowski S; Sill M; Varghese J; Afflerbach AK; Eckhardt A; Münter D; Verma A; Struve N; Jones DTW; Remke M; Neumann JE; Kerl K; Schüller U
    Nat Commun; 2023 Nov; 14(1):7717. PubMed ID: 38001143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
    Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
    Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new era for children with diffuse intrinsic pontine glioma: hope for cure?
    Jansen MH; Kaspers GJ
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1109-12. PubMed ID: 23098109
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
    Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
    Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
    Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
    Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
    Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
    Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.
    Pratt D; Quezado M; Abdullaev Z; Hawes D; Yang F; Garton HJL; Judkins AR; Mody R; Chinnaiyan A; Aldape K; Koschmann C; Venneti S
    Acta Neuropathol Commun; 2020 Mar; 8(1):37. PubMed ID: 32197665
    [No Abstract]   [Full Text] [Related]  

  • 19. Biopsy for diffuse intrinsic pontine glioma: a reappraisal.
    Kieran MW; Goumnerova LC; Prados M; Gupta N
    J Neurosurg Pediatr; 2016 Sep; 18(3):390-1. PubMed ID: 27153377
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects.
    Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO
    Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.